Trends in the Use of Intracytoplasmic Sperm Injection in the United States
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Intracytoplasmic sperm injection (ICSI) was initially developed as part of in vitro fertilization (IVF) to treat male-factor infertility. However, despite the added cost, uncertain efficacy, and potential risks of ICSI, its use has been extended to include some patients without documented male-factor infertility. METHODS: We analyzed national data on assisted reproductive technology reported to the Centers for Disease Control and Prevention, to determine temporal trends in the use of ICSI and IVF in the United States, and we examined differences in the use of ICSI between states with and those without mandated insurance coverage. RESULTS: From 1995 to 2004, the number of fertility clinics and fresh-embryo cycles and the rates of IVF-related pregnancies and live births increased. The percentage of IVF cycles with the use of ICSI also increased dramatically (from 11.0% to 57.5%), while the percentage of diagnoses of infertility attributed to male-factor conditions remained stable. The ratio of ICSI procedures to diagnoses of male-factor infertility steadily increased each year, suggesting an increasing use of ICSI for conditions other than male-factor infertility. From 1999 to 2004, there was an increasing use of ICSI relative to the percentage of patients with male-factor infertility in states with and those without mandated insurance coverage. For any given year, however, states with insurance coverage had a higher ratio of ICSI use to diagnoses of male-factor infertility than did states without insurance coverage (P<0.001). CONCLUSIONS: Since 1995, the use of ICSI in the United States has increased dramatically, while the proportion of patients receiving treatment for male-factor infertility has remained stable. State-mandated health insurance coverage for IVF services is associated with greater use of ICSI for infertility that is not attributed to male-factor conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reschovsky, J. D., Hadley, J., & Landon, B. E. (2006) · Health Services Research · doi:10.1111/j.1475-6773.2006.00531.x · Cited by 57
Cited by
Nyboe Andersen, A., Goossens, V., Bhattacharya, S., Ferraretti, A. P., Kupka, M. S., de Mouzon, J., & Nygren, K. G. (2009) · Human Reproduction · doi:10.1093/humrep/dep035 · Cited by 599
Assisted reproductive technology in Europe, 2004: results generated from European registers by ESHRE
Nyboe Andersen, A., Goossens, V., Ferraretti, A. P., Bhattacharya, S., Felberbaum, R., de Mouzon, J., Nygren, K. G., & The European IVF-monitoring (EIM) Consortium, F. T. E. S. O. H. R. A. E. (. (2008) · Human Reproduction · doi:10.1093/humrep/den014 · Cited by 566
Baazeem, A., Belzile, E., Ciampi, A., Dohle, G., Jarvi, K., Salonia, A., Weidner, W., & Zini, A. (2011) · European Urology · doi:10.1016/j.eururo.2011.06.018 · Cited by 486
Assisted reproductive technology in Europe, 2010: results generated from European registers by ESHRE
Kupka, M. S., Ferraretti, A. P., de Mouzon, J., Erb, K., D'Hooghe, T., Castilla, J. A., Calhaz-Jorge, C., De Geyter, C., Goossens, V., Strohmer, H., et al. (2014) · Human Reproduction · doi:10.1093/humrep/deu175 · Cited by 462
Assisted reproductive technology in Europe, 2006: results generated from European registers by ESHRE
de Mouzon, J., Goossens, V., Bhattacharya, S., Castilla, J. A., Ferraretti, A. P., Korsak, V., Kupka, M., Nygren, K. G., Nyboe Andersen, A., & The European IVF-monitoring (EIM) Consortium, F. T. E. S. O. H. R. A. E. (. (2010) · Human Reproduction · doi:10.1093/humrep/deq124 · Cited by 414
Metadata
- Authors
- Jain, T., & Gupta, R. S.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2007-07-19
- Volume
- 357
- Issue
- 3
- Pages
- 251-257
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2022290943
- Cited by
- 137
- References
- 1
- FWCI
- 9.09
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.